

Mylan Strikes $7.2 Billion Deal for Meda as Earnings Miss


? 
Price represents a 92% premium to Meda's close on Wednesday 

? 
Meda board has recommended offer be accepted, Mylan says 



Mylan NV said it will buy Meda AB in a cash and stock deal worth about $7.2 billion, adding the Swedish companyâ€™s specialty drug products and European operations.
